Comments
Loading...

Stock Price, Quotes and Forecasts

CNCR
Logo brought to you by Benzinga Data
Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Sector
Healthcare
Region
US
AUM
6.95M
Fund Score

Price, Quotes and Forecasts | :CNCR | Benzinga

Explore stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CNCR.

Open-
High-
52 Wk High-
AUM6.95M
Dividend-
Ex-Div Date-
Volume-
Market Cap$9.06B
Mgmt Fee0.79%
P/E Ratio37.64
Prev. Close-
Low-
52 Wk Low-
Shares Out1.18M
Yield-
Div. Freq-
Avg. Volume Daily1.05K
Beta0.88
Avg. Expense Ratio0.79%
P/B Ratio1.31
About
Sector
N/A
Industry
N/A
ETF Details
SectorHealthcare
CategoryHigh Performer-High Growth
Investment StyleSmall Cap Blend
Fund InceptionOct 13, 2015
Managers
Brian Cooper
Andrew Serowik
Todd Alberico
Gabriel Tan
DefinitionAn equity fund portfolio full of stocks with both strong financial performance and superior growth potential
Investment Policy
The Fund uses a passive management (or indexing) approach to track the performance, before fees and expenses, of the Index. The Fund attempts to invest all, or substantially all, of its assets in the component securities that make up the Index. Under normal circumstances, at least 80 percent of the Funds total assets (exclusive of any collateral held from securities lending) will be invested in the component securities of the Index. Exchange Traded Concepts, LLC (ETC or the Adviser), the Funds investment adviser, expects that, over time, the correlation between the Funds performance and that of the Index, before fees and expenses, will be 95 percent or better.
Top ETF Holdings
SymbolNameShare %
JANXJanux Therapeutics Inc...4.17%
MGNXMacrogenics Inc3.27%
MRSNMersana Therapeutics I...3.26%
YMABY-Mabs Therapeutics In...2.85%
FATEFate Therapeutics Inc1.80%
IOVAIovance Biotherapeutic...2.57%
AMAMAmbrx Inc2.54%
IBRXImmunitybio Inc.1.79%
SMMTSummit Therapeutics Pl...2.19%
RVMDRevolution Medicines I...1.83%
RXRXRecursion Pharmaceutic...3.64%
GLUEMonte Rosa Therapeutic...2.07%
DNAGinkgo Bioworks Holdin...2.20%
REPLReplimune Group Inc Co...2.00%
EXELExelixis Inc1.81%
XNCRXencor Inc1.71%
BMYBristol-Myers Squibb C...1.76%
SWTXSpringworks Therapeuti...2.54%
PGENPrecigen Inc Common St...3.39%
GNLXGenelux Corp3.01%
CMPXCOMPASS THERAPEUTICS I...2.87%
RAPTRapt Therapeutics Inc1.89%
LYELLyell Immunopharma Inc...1.80%
INBXInhibrx Biosciences In...1.74%
TSVT2Seventy Bio Inc1.83%
HCMHutchison China Medite...1.78%
IMCRImmunocore Holdings Lt...1.71%
BPMCBlueprintmedicines Cor...1.96%
PAInnate Pharma Sa-Spons...2.02%
STROSutro Biopharma Inc1.85%
NUVBNuvation Bio Inc1.82%
SDGRSchrodinger, Inc.1.80%
COGenmab A/s ADR1.78%